Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (171-180 of 221) with videos related to

Pageof 23
Sort By:
Eclinicalmedicine|January 13, 2025
Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trialArndt Stahler, Meinolf Karthaus, Stefan Fruehauf, et al.
Genes, Chromosomes & Cancer|April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assaysMartina Kirchner, Julia Glade, Ulrich Lehmann, et al.
Journal of Translational Medicine|March 5, 2026
Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacyAgnes K Böhm, Lisa M Skrip, Oliver Klein, et al.
EMBO Molecular Medicine|August 19, 2021
Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancerFlorian Uhlitz, Philip Bischoff, Stefan Peidli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2025
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in <i>RAS</i> Wild-Type Metastatic Colorectal CancerArndt Stahler, Dominik Paul Modest, Sebastian Stintzing, et al.
Journal of Neuro-Oncology|December 4, 2024
TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progressionDavid Wasilewski, Tommaso Araceli, Philip Bischoff, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
Nature Communications|April 20, 2018
Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammationJoachim Pircher, Thomas Czermak, Andreas Ehrlich, et al.
The Journal of Pathology|June 25, 2025
Mucinous cystic neoplasms of the pancreas and liver share a similar DNA methylation profile with mucinous ovarian tumorsZoe Leoni, Teodor G Calina, Tobias Janik, et al.
Clinical Epigenetics|November 10, 2024
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sitesTeodor G Calina, Eilís Perez, Elena Grafenhorst, et al.
Pageof 23

Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Eclinicalmedicine|January 13, 2025
Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trialArndt Stahler, Meinolf Karthaus, Stefan Fruehauf, et al.
Genes, Chromosomes & Cancer|April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assaysMartina Kirchner, Julia Glade, Ulrich Lehmann, et al.
Journal of Translational Medicine|March 5, 2026
Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacyAgnes K Böhm, Lisa M Skrip, Oliver Klein, et al.
EMBO Molecular Medicine|August 19, 2021
Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancerFlorian Uhlitz, Philip Bischoff, Stefan Peidli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2025
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in <i>RAS</i> Wild-Type Metastatic Colorectal CancerArndt Stahler, Dominik Paul Modest, Sebastian Stintzing, et al.
Journal of Neuro-Oncology|December 4, 2024
TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progressionDavid Wasilewski, Tommaso Araceli, Philip Bischoff, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
Nature Communications|April 20, 2018
Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammationJoachim Pircher, Thomas Czermak, Andreas Ehrlich, et al.
The Journal of Pathology|June 25, 2025
Mucinous cystic neoplasms of the pancreas and liver share a similar DNA methylation profile with mucinous ovarian tumorsZoe Leoni, Teodor G Calina, Tobias Janik, et al.
Clinical Epigenetics|November 10, 2024
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sitesTeodor G Calina, Eilís Perez, Elena Grafenhorst, et al.
Pageof 23